Brief

Bioengineering board: Cornell's newly approved M.S./Ph.D. program in biomedical engineering in the School of Chemical Engineering has added three new corporate members to its advisory board. They are: Rebecca Robertson '82, a partner and managing director of IVP, a California-based venture capital firm; David R. Fischell '75, founder of NeuroPace Inc., IsoStent Inc. and Cathco Inc., three biomedical device companies; and Samuel E. Navarro of the investment banking firm ING Barings Furman Selz LLC. The 15-member board provides guidance on the development of the bioengineering program, particularly in helping find ways for the program to maximize its effectiveness in both education and scholarly research.